CDT
CDT Equity Inc. Common Stock
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$1.06
$-0.27
(-20.30%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $2.44M | EPS (ttm) | $-179.34 | Current Price | $1.06 |
| Enterprise Value | $204.10K | Forward EPS | - | Previous Close | $1.33 |
| P/E Ratio | - | ROA | -206.95% | 52W High | $444.00 |
| Forward P/E | - | ROE | - | 52W Low | $1.04 |
| PEG Ratio | - | Gross Margin | - | 50 Day Avg | $1.54 |
| P/S Ratio | - | Operating Margin | - | 200 Day Avg | $14.89 |
| P/B Ratio | 0.32 | Profit Margin | - | Volume | 622.54K |
| EV/EBITDA | -0.01 | Current Ratio | 1.66 | Avg Volume | 550.44K |
| EV/Sales | - | Quick Ratio | 0.99 | Beta | 1.77 |
| Employees | 6.00 | Debt/Equity | 43.83 | Shares Outstanding | 2.30M |
| Sector | Healthcare | Total Debt | $1.88M | Float Shares | 1.18M |
| Industry | Biotechnology | Total Cash | $3.84M | Short Float | 3.76% |
| Optionable | No | Cash/Share | $2.35 | Short Ratio | 1.21 |
| Dividend Yield | - | Book Value/Share | $3.35 | % Held by Insiders | 25.97% |
| Target Price | - | Revenue (TTM) | - | % Held by Institutions | 1.02% |